IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.
Shigella flexneri causes human dysentery after invading the cells of the colonic epithelium. The best-studied effectors of Shigella entry into colonocytes are the invasion plasmid antigens IpaC and IpaB. These proteins are exported via a type III secretion system (TTSS) to form a pore in the host membrane that may allow the translocation of other effectors into the host cytoplasm. TTSS-mediated secretion of IpaD is also required for translocation pore formation, bacterial invasion, and virulence, but the mechanistic role of this protein is unclear. IpaD is also known to be involved in controlling Ipa protein secretion, but here it is shown that this activity can be separated from its requirement for cellular invasion. Amino acids 40 to 120 of IpaD are not essential for IpaD-dependent invasion; however, deletions in this region still lead to constitutive IpaB/IpaC secretion. Meanwhile, a central deletion causes only a partial loss of control of Ipa secretion but completely eliminates IpaD's invasion function, indicating that IpaD's role in invasion is not a direct outcome of its ability to control Ipa secretion. As shigellae expressing ipaD N-terminal deletion mutations have reduced contact-mediated hemolysis activity and are less efficient at introducing IpaB and IpaC into erythrocyte membranes, it is possible that IpaD is responsible for insertion of IpaB/IpaC pores into target cell membranes. While efficient insertion of IpaB/IpaC pores is needed for optimal invasion efficiency, it may be especially important for Ipa-dependent membrane disruption and thus for efficient vacuolar escape and intercellular spread.
Picking
Wendy L
WL
Department of Molecular Biosciences, University of Kansas, 1200 Sunnyside Ave., Lawrence, KS 66045, USA. picking@ku.edu
Nishioka
Hiroaki
H
Hearn
Patricia D
PD
Baxter
M Aaron
MA
Harrington
Amanda T
AT
Blocker
Ariel
A
Picking
William D
WD
D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics / Q000378:metabolism*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D004910:Erythrocyte Membrane / Q000378:metabolism / Q000382:microbiology; D017353:Gene Deletion; D015964:Gene Expression Regulation, Bacterial; D006461:Hemolysis; D006801:Humans; D007422:Intestines / Q000166:cytology / Q000382:microbiology; D012763:Shigella flexneri / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C095770:IpaD protein, Shigella flexneri; C087447:ipaB protein, Shigella; C092342:IpaC protein, Shigella
Infect Immun. 1985 Apr;48(1):124-9
3884506
Mol Microbiol. 1997 May;24(4):697-709
9194698
Microbiol Rev. 1991 Jun;55(2):206-24
1886518
Mol Microbiol. 1993 Jan;7(1):59-68
8437520
J Bacteriol. 1993 Sep;175(18):5899-906
8376337
Cell. 1994 Nov 4;79(3):515-25
7954817
EMBO J. 1994 Nov 15;13(22):5293-302
7957095
Infect Immun. 1995 Oct;63(10):3927-35
7558301
Biochem Biophys Res Commun. 1995 Sep 25;214(3):963-70
7575570
J Bacteriol. 1995 Dec;177(24):7078-85
8522512
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1254-8
8577750
J Bacteriol. 1998 Mar;180(5):1207-14
9495760
Infect Immun. 1998 May;66(5):1999-2006
9573082
Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433
9618447
J Bacteriol. 1998 Jul;180(13):3410-20
9642196
Biochim Biophys Acta. 1998 Dec 8;1429(1):45-56
9920383
Mol Microbiol. 1999 Jun;32(5):961-76
10361299
EMBO J. 1999 Jun 15;18(12):3249-62
10369666
Infect Immun. 1999 Oct;67(10):5395-408
10496922
Microb Pathog. 1999 Oct;27(4):223-30
10502463
J Cell Biol. 1999 Nov 1;147(3):683-93
10545510
J Bacteriol. 2001 Sep;183(17):5082-91
11489861
J Biol Chem. 2001 Aug 24;276(34):32230-9
11413141
Mol Microbiol. 2001 Oct;42(2):469-81
11703668
J Bacteriol. 2001 Dec;183(24):6991-8
11717255
Infect Immun. 2003 Mar;71(3):1255-64
12595440
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3027-30
12631703
Structure. 2004 Feb;12(2):301-6
14962390
Infect Immun. 2004 Aug;72(8):4741-50
15271936
Anal Biochem. 1976 May 7;72:248-54
942051
Trends Microbiol. 2000 May;8(5):202-4
10785634
Mol Microbiol. 2001 Jan;39(1):100-11
11123692
Mol Microbiol. 2001 Feb;39(3):620-32
11169103
Cell Microbiol. 2000 Jun;2(3):187-93
11207575
J Exp Med. 1996 Mar 1;183(3):991-9
8642302
EMBO J. 1996 Aug 1;15(15):3853-60
8670890
Infect Immun. 1996 Oct;64(10):4182-7
8926086
J Bacteriol. 1997 Feb;179(4):1307-16
9023216
Infect Immun. 1986 Feb;51(2):461-9
3510976